In vitro binding affinities of 4-chloro-, 2-methyl-, 4-methyl-, and 4-ethylindoleacetic acid to auxin-binding protein 1 (ABP1) correlate with their growth-stimulating activities

1996 ◽  
Vol 15 (1) ◽  
pp. 1-3 ◽  
Author(s):  
U. Rescher ◽  
A. Walther ◽  
C. Schiebl ◽  
D. Klämbt
2014 ◽  
Vol 24 (9) ◽  
pp. 1463-1474 ◽  
Author(s):  
Johanna Michl ◽  
Christian Scharinger ◽  
Miriam Zauner ◽  
Siegfried Kasper ◽  
Michael Freissmuth ◽  
...  

Planta ◽  
1997 ◽  
Vol 201 (4) ◽  
pp. 470-476 ◽  
Author(s):  
Christine Schiebl ◽  
Antje Walther ◽  
Ursula Rescher ◽  
Dieter Klämbt

ChemInform ◽  
2010 ◽  
Vol 33 (9) ◽  
pp. no-no
Author(s):  
Joo Hwan Cha ◽  
Yong Seo Cho ◽  
Ae Nim Pae ◽  
Hun Yeong Koh ◽  
Daeyoung Jeong ◽  
...  

mAbs ◽  
2009 ◽  
Vol 1 (5) ◽  
pp. 491-504 ◽  
Author(s):  
Yin Luo ◽  
Zhaojiang Lu ◽  
Stephen W. Raso ◽  
Clifford Entrican ◽  
Bruce Tangarone

Planta ◽  
1984 ◽  
Vol 160 (2) ◽  
pp. 102-108 ◽  
Author(s):  
P. C. G. van der Linde ◽  
H. Bouman ◽  
A. M. Mennes ◽  
K. R. Libbenga

2001 ◽  
Vol 11 (21) ◽  
pp. 2855-2857 ◽  
Author(s):  
Joo Hwan Cha ◽  
Yong Seo Cho ◽  
Ae Nim Pae ◽  
Hun Yeong Koh ◽  
Daeyoung Jeong ◽  
...  

2019 ◽  
Author(s):  
Filip Fratev ◽  
Denisse A. Gutierrez ◽  
Renato J. Aguilera ◽  
suman sirimulla

AKT1 is emerging as a useful target for treating cancer. Herein, we discovered a new set of ligands that inhibit the AKT1, as shown by in vitro binding and cell line studies, using a newly designed virtual screening protocol that combines structure-based pharmacophore and docking screens. Taking together with the biological data, the combination of structure based pharamcophore and docking methods demonstrated reasonable success rate in identifying new inhibitors (60-70%) proving the success of aforementioned approach. A detail analysis of the ligand-protein interactions was performed explaining observed activities.<br>


Sign in / Sign up

Export Citation Format

Share Document